首页> 外国专利> A long-term QT syndrome gene encoding KVLQT1 and a combination of KVLQT1 and MINK

A long-term QT syndrome gene encoding KVLQT1 and a combination of KVLQT1 and MINK

机译:编码KVLQT1的长期QT综合征基因以及KVLQT1和MINK的组合

摘要

One aspect of the present invention relates to the identification of the molecular system of long-term QT syndrome. More specifically, the present invention has confirmed that mutated KVLQT1 causes long-term QT syndrome. Analysis of this gene will provide early detection of subjects with long-term QT syndrome. This diagnostic method consists of analyzing the nucleic acid sequence of the KVLQT1 gene of the subject and comparing it with the nucleic acid sequence of the natural, non-variable gene. In addition, the amino acid sequence of KVLQT1 can be analyzed for mutations that cause long-term QT syndrome. The pre-symptomatic diagnosis of long-term QT syndrome will enable doctors to treat this disease using current medical therapies. The second aspect of the invention relates to the understanding that KVLQT1 associates with minK to form cardiac potassium channels. This allows us to identify new drugs useful for treating or preventing long-term QT by analyzing drugs that interact with this channel.
机译:本发明的一个方面涉及长期QT综合征的分子系统的鉴定。更具体地,本发明已经证实突变的KVLQT1引起长期QT综合征。对该基因的分析将提供对患有长期QT综合征的受试者的早期检测。该诊断方法包括分析受试者的KVLQT1基因的核酸序列,并将其与天然的,不变的基因的核酸序列进行比较。此外,可以分析KVLQT1的氨基酸序列中引起长期QT综合征的突变。长期QT综合征的症状前诊断将使医生能够使用当前的药物治疗该疾病。本发明的第二方面涉及这样的理解,即KVLQT1与minK缔合形成心脏钾通道。这使我们能够通过分析与该通道相互作用的药物来鉴定可用于治疗或预防长期QT的新药物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号